Browsing by Author Bruix Tudó, Jordi
Showing results 1 to 20 of 20
| Issue Date | Title | Author(s) |
|---|---|---|
| 10-Mar-2010 | Actitud a seguir ante la detección de una lesión focal inferior o igual a 2 cm de tamaño en un paciente con cirrosis hepática | Forner González, Alejandro |
| 1-Jan-2016 | Akt-mediated FoxO1 inhibition is required for liver regeneration | Pauta, Montse; Rotllan, Noemi; Fernández Hernando, Ana; Langhi, Cedric; Ribera Sabaté, Jordi; Boix i Ferrero, Loreto; Bruix Tudó, Jordi; Jiménez Povedano, Wladimiro; Duarez, Yajaira; Ford, David A.; Baldán, Morris J.; Bimbaum, Morris J.; Morales Ruiz, Manuel; Fernández Hernando, Carlos |
| 28-May-2021 | Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity | Fernández Tussy, Pablo; Rodríguez Agudo, Rubén; Fernández Ramos, David; Barbier Torres, Lucía; Zubiete Franco, Imanol; López de Davalillo, Sergio; Herraez, Elisa; Goikoetxea Usandizaga, Naroa; Lachiondo Ortega, Sofia; Simón, Jorge; Lopitz Otsoa, Fernando; Gutiérrez de Juan, Virginia; Mccain, Misti V.; Perugorria, Maria J.; Mabe, Jon; Navasa, Nicolás; Rodrigues, Cecilia M. P.; Fabregat, Isabel; Boix i Ferrero, Loreto; Sapena, Victor; Anguita, Juan; Lu, Shelly C.; Mato, José M.; Banales, Jesus M.; Villa, Erica; Reeves, Helen L.; Bruix Tudó, Jordi; Reig, María; Marin, Jose J. G.; Delgado, Teresa C.; Martínez Chantar, Maria Luz |
| 30-Mar-2018 | Antiapoptotic BCL-2 proteins determine Sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma | Tutusaus, Anna; Stefanovic, Milica; Boix i Ferrero, Loreto; Cucarull, Blanca; Zamora, Aynara; Blasco, Laura; García de Frutos, Pablo; Reig, María; Fernández-Checa Torres, José Carlos; Marí García, Montserrat; Colell Riera, Anna; Bruix Tudó, Jordi; Morales Muñoz, Albert |
| Oct-2020 | Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma | Fernández Varo, Guillermo; Perramón, Meritxell; Carvajal Romero, Silvia; Oró Bozzini, Denise; Casals, Eudald; Boix i Ferrero, Loreto; Oller, Laura; Macías-Muñoz, Laura; Marfà Bruix, Santiago; Casals, Gregori; Morales Ruiz, Manuel; Casado, Pedro; Cutillas, Pedro R.; Bruix Tudó, Jordi; Navasa, Miquel; Fuster Obregón, Josep; García-Valdecasas Salgado, Juan Carlos; Pavel, Mihai; Puntes, Víctor; Jiménez Povedano, Wladimiro |
| 21-Jun-2017 | Caracterización de células tumorales circulantes en pacientes con carcinoma hepatocelular. Función de EpCAM en la metástasis | Rhodes Cabrerizo, Ana Carolina |
| 1988 | Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathy | Cervera i Segura, Ricard, 1960-; Bruix Tudó, Jordi; Bayés Rusiñol, Àngels; Blesa González, Rafael; Illa Sendra, Isabel; Coll, J.; García Pugés, Antonio Manuel |
| 2-Jan-2018 | Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events. | Rimola, Jordi; Díaz González, Álvaro; Reig, María; Darnell, Anna; Varela, María; Pons, Fernando; Hernández Guerra, Manuel; Delgado, Manuel; Castroagudin, Javier; Matilla, Ana; Sangro, Bruno; Rodriguez de Lope, Carlos; Sala, Margarita; Gonzalez, Carmen; Huertas, Carlos; Minguez, Beatriz; Ayuso Colella, Carmen; Bruix Tudó, Jordi |
| 2002 | Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. | Llovet i Bayer, Josep Maria; Mas, X.; Aponte, John J.; Fuster Obregón, Josep; Navasa, Miquel; Christensen, E.; Rodés, J.; Bruix Tudó, Jordi |
| 6-Jul-2021 | Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs | Díaz González, Álvaro; Sapena, Victor; Boix i Ferrero, Loreto; Torres, Ferram; Sanduzzi-Zamparelli, Marco; Da Fonseca, Leonardo G.; Llarch, Neus; Iserte, Gemma; Guedes, Cassia; Muñoz Martínez, Sergio; Darnell, Anna; Belmonte, Ernest; Rimola, Jordi; Forner, Alejandro; Ayuso Colella, Carmen; Bruix Tudó, Jordi; Reig, María |
| 1998 | Hepatitis G virus infection in chronic liver disease | Guilera Sardà, Magda; Sáiz Calahorra, Juan Carlos; López Labrador, Francesc Xavier; Olmedo Casas, Eva; Ampurdanés, Sergi; Forns, Xavier; Bruix Tudó, Jordi; Parés Darnaculleta, Albert; Sánchez Tapias, José M. (José María); Jiménez de Anta Losada, María Teresa; Rodés, J. |
| 2001 | Hepatocellular carcinoma: is surveillance cost effective? | Bruix Tudó, Jordi; Llovet i Bayer, Josep Maria |
| 1-Jun-2018 | Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial | Pinyol, Roser; Montal, Robert; Bassaganyas, Laia; Sia, Daniela; Takayama, Tadatoshi; Chau, Gar-Yang; Mazzaferro, Vincenzo; Roayaie, Sasan; Lee, Han Chu; Kokudo, Norihiro; Zhang, Zhongyang; Torrecilla, Sara; Moeini, Agrin; Rodriguez-Carunchio, Leonardo; Gane, Edward; Verslype, Chris; Croitoru, Adina Emilia; Cillo, Umberto; de la Mata, Manuel; Lupo, Luigi; Strasser, Simone; Park, Joong-Won; Camps, Jordi; Solé, Manel; Thung, Swan N.; Villanueva, Augusto; Pena, Carol; Meinhardt, Gerold; Bruix Tudó, Jordi; Llovet i Bayer, Josep Maria |
| 15-Nov-2017 | Pilot study of living donor liver transplantation for patients with HCC exceeding Milan criteria | Llovet i Bayer, Josep Maria; Pavel, Mihai; Rimola, Jordi; Diaz, Maria Alba; Colmenero, Jordi; Saavedra Pérez, David; Fondevila Campo, Constantino; Ayuso Colella, Carmen; Fuster Obregón, Josep; Ginès i Gibert, Pere; Bruix Tudó, Jordi; García-Valdecasas Salgado, Juan Carlos |
| 17-Dec-2020 | Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice | Rimola, Jordi; Da Fonseca, Leonardo G.; Sapena, Victor; Perelló, Chistie; Guerrero, Antonio; Torner Simó, Maria; Pons, Mònica; De la Torre Aláez, Manuel; Calleja Panero, José Luis; Lledó, José L.; Varela, Maria; Mínguez, Beatriz; Sangro, Bruno; Matilla, Ana; Torres, Ferran; Ayuso Colella, Carmen; Bruix Tudó, Jordi; Reig, María; Márquez, Laura |
| 1-Feb-2020 | Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models | Cucarull, Blanca; Tutusaus, Anna; Subias, Miguel; Tutusaus, Anna; Hernáez Alsina, Tania; Boix i Ferrero, Loreto; Reig, María; García de Frutos, Pablo; Marí García, Montserrat; Colell Riera, Anna; Bruix Tudó, Jordi; Morales Muñoz, Albert |
| 1-Nov-2016 | Restoring mir122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through smad-independent TGF-β pathway. | Boix i Ferrero, Loreto; López-Oliva, Juan Manuel; Rhodes Cabrerizo, Ana Carolina; Bruix Tudó, Jordi |
| 20-Feb-2014 | Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma | Zhu, Andrew X.; Rosmorduc, Olivier; Evans, T.R. Jeffry; Ross, Paul J.; Santoro, Armando; Carrilho, Flair José; Bruix Tudó, Jordi; Qin, Shukui; Thuluvath, Paul J.; Llovet i Bayer, Josep Maria; Leberre, Marie-Aude; Jensen, Markus; Meinhardt, Gerold; Kang, Yoon-Koo |
| 11-Dec-2014 | Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer | Barbier Torres, Lucía; Delgado, Teresa C.; García Rodríguez, Juan L.; Zubiete Franco, Imanol; Fernández Ramos, David; Buqué, Xabier; Cano, Ainara; Gutiérrez de Juan, Virginia; Fernández Domínguez, Itziar; Lopitz Otsoa, Fernando; Fernández Tussy, Pablo; Boix i Ferrero, Loreto; Bruix Tudó, Jordi; Villa, Erica; Castro, Azucena; Lu, Shelly C.; Aspichueta, Patricia; Xirodimas, Dimitris; Varela Rey, Marta; Mato, José M.; Beraza, Naiara; Martínez Chantar, Maria Luz |
| 21-Jun-1994 | Tractament del carcinoma hepatocel·lular avançat mitjançant embolització de l'artèria hepàtica | Castells Garangou, Antoni |